Roche Raises Earnings Forecast as Cost Reductions Beat Goal
This article is for subscribers only.
Roche Holding AG, the world’s biggest maker of cancer drugs, raised its profit forecast, citing savings from a cost-cutting plan, even as second-quarter sales slumped.
Earnings per share excluding some items will rise by about 10 percent in local currencies this year, the Basel, Switzerland-based company said today in a statement. Roche on Feb. 2 had forecast a profit increase in the high single-digits.